| MRI-targeted or standard biopsy for prostate-cancer diagnosis V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ... New England Journal of Medicine 378 (19), 1767-1777, 2018 | 2035 | 2018 |
| Active surveillance for low-risk prostate cancer worldwide: the PRIAS study M Bul, X Zhu, R Valdagni, T Pickles, Y Kakehi, A Rannikko, A Bjartell, ... European urology 63 (4), 597-603, 2013 | 573 | 2013 |
| Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review IG Schoots, N Petrides, F Giganti, LP Bokhorst, A Rannikko, L Klotz, ... European urology 67 (4), 627-636, 2015 | 364 | 2015 |
| Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer B Sahu, M Laakso, K Ovaska, T Mirtti, J Lundin, A Rannikko, A Sankila, ... The EMBO journal 30 (19), 3962-3976, 2011 | 364 | 2011 |
| Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly RCN van den Bergh, S Roemeling, MJ Roobol, G Aus, J Hugosson, ... European urology 55 (1), 1-8, 2009 | 322 | 2009 |
| A decade of active surveillance in the PRIAS study: an update and evaluation of the criteria used to recommend a switch to active treatment LP Bokhorst, R Valdagni, A Rannikko, Y Kakehi, T Pickles, CH Bangma, ... European urology 70 (6), 954-960, 2016 | 303 | 2016 |
| Ontogeny of follicle-stimulating hormone receptor gene expression in the rat testis and ovary HIT Rannikki A S, Zhang F P Molecular and Cellular Endocrinology 107 (2), 199-208, 1995 | 210 | 1995 |
| Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: the PRECISE recommendations—a report of a European School of Oncology Task Force CM Moore, F Giganti, P Albertsen, C Allen, C Bangma, A Briganti, ... European urology 71 (4), 648-655, 2017 | 193 | 2017 |
| Short‐term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’study RCN Van Den Bergh, H Vasarainen, HG Van Der Poel, JJ Vis‐Maters, ... BJU international 105 (7), 956-962, 2010 | 189 | 2010 |
| Gonadotropin-independent regulation of steroidogenesis in the fetal rat testis F El-Gehani, FP Zhang, P Pakarinen, A Rannikko, I Huhtaniemi Biology of reproduction 58 (1), 116-123, 1998 | 179 | 1998 |
| Outcomes of initially expectantly managed patients with low or intermediate risk screen‐detected localized prostate cancer M Bul, RCN van den Bergh, X Zhu, A Rannikko, H Vasarainen, ... BJU international 110 (11), 1672-1677, 2012 | 159 | 2012 |
| Active surveillance for prostate cancer: a narrative review of clinical guidelines SM Bruinsma, CH Bangma, PR Carroll, MS Leapman, A Rannikko, ... Nature Reviews Urology 13 (3), 151-167, 2016 | 152 | 2016 |
| Metabolomic profiling of extracellular vesicles and alternative normalization methods reveal enriched metabolites and strategies to study prostate cancer-related changes M Puhka, M Takatalo, ME Nordberg, S Valkonen, J Nandania, M Aatonen, ... Theranostics 7 (16), 3824, 2017 | 145 | 2017 |
| Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion M Björkman, P Östling, V Härmä, J Virtanen, JP Mpindi, J Rantala, T Mirtti, ... Oncogene 31 (29), 3444-3456, 2012 | 114 | 2012 |
| Compliance rates with the Prostate Cancer Research International Active Surveillance (PRIAS) protocol and disease reclassification in noncompliers LP Bokhorst, AR Alberts, A Rannikko, R Valdagni, T Pickles, Y Kakehi, ... European urology 68 (5), 814-821, 2015 | 113 | 2015 |
| Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study M Bul, X Zhu, A Rannikko, F Staerman, R Valdagni, T Pickles, ... European urology 62 (2), 195-200, 2012 | 112 | 2012 |
| Tranexamic acid in control of primary hemorrhage during transurethral prostatectomy A Rannikko, A Pétas, K Taari Urology 64 (5), 955-958, 2004 | 111 | 2004 |
| Functional characterization of the human FSH receptor with an inactivating Ala189Val mutation A Rannikko, P Pakarinen, PR Manna, I Beau, M Misrahi, K Aittomäki, ... Molecular human reproduction 8 (4), 311-317, 2002 | 102 | 2002 |
| Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins P Vainio, L Lehtinen, T Mirtti, M Hilvo, T Seppänen-Laakso, J Virtanen, ... Oncotarget 2 (12), 1176, 2011 | 97 | 2011 |
| Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program M Bul, RCN Van Den Bergh, A Rannikko, R Valdagni, T Pickles, ... European urology 61 (2), 370-377, 2012 | 87 | 2012 |
Tom PicklesBC Cancer AgencyVerified email at bccancer.bc.ca
